Erlotinib Impurity 70 CAS CATO-C4X-106970

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-106970
Molecular FormulaC15H21NO8
Molecular Weight343.33 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Erlotinib Impurity 70 CAS CATO-C4X-106970 chemical structure

Description

Owing to a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, Erlotinib Impurity 70 is typically off-white to pale yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 343.33 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

CATO supplies Erlotinib Impurity 70 (CAS CATO-C4X-106970), a pharmacopoeial impurity reference standard (molecular formula C15H21NO8, MW 343.33 g/mol) used for the identification and quantification of trace impurities in APIs.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

CATO manufactures Erlotinib Impurity 70 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC15H21NO8
Molecular Weight343.33 g/mol
AppearanceOff-white to pale yellow crystalline powder
Purity97%+
StorageStore at 2-8°C, protect from light, keep sealed and dry
Solubility (reference)Soluble in methanol, acetonitrile, DMSO, water (slightly soluble)
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light
Degree of Unsaturation (DBE)6.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
Nitrogen Atoms1

Related Erlotinib Standards

Recommended Standards

Why CATO?